Aplasia Clinical Trials

21 recruitingLast updated: June 18, 2026

There are 21 actively recruiting aplasia clinical trials across 11 countries. Studies span Not Applicable, Phase 2, Phase 4. Top locations include Xi'an, Shaanxi, China, New York, New York, United States, Bristol, South West, United Kingdom. Updated daily from ClinicalTrials.gov.


Aplasia Trials at a Glance

21 actively recruiting trials for aplasia are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Xi'an, New York, and Bristol. Lead sponsors running aplasia studies include Yongquan Shi, Chinese University of Hong Kong, and Instituto Portugues de Oncologia, Francisco Gentil, Porto.

Browse aplasia trials by phase

Treatments under study

About Aplasia Clinical Trials

Looking for clinical trials for Aplasia? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Aplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Aplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting
Phase 2

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

Severe Aplastic AnemiaAcquired Amegakaryocytic ThrombocytopeniaAcquired Pure Red Cell Aplasia+1 more
Masonic Cancer Center, University of Minnesota60 enrolled1 locationNCT06412497
Recruiting
Phase 2

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Sickle Cell DiseaseStem Cell Transplant ComplicationsPure Red Cell Aplasia+1 more
University of Calgary12 enrolled1 locationNCT03214354
Recruiting

Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis

Gastric CarcinomaIntestinal MetaplasiaGastritis Chronic+1 more
Yongquan Shi450 enrolled1 locationNCT07542652
Recruiting

Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

Aplasia Cutis Congenita
UConn Health600 enrolled1 locationNCT01630421
Recruiting

Endoscopic Screening of Asymptomatic Patients for Helicobacter Pylori, Intestinal Metaplasia, and Barrett's Mucosa During Screening Colonoscopy

Helicobacter Pylori InfectionsIntestinal MetaplasiaBarett's Esophagus
Sigmund Freud PrivatUniversitat1,000 enrolled1 locationNCT07346521
Recruiting
Phase 2

REVerse Intestinal Metaplasia in the Stomach (REVISE)

Gastric Intestinal MetaplasiaGastric Precancer
Katherine Garman32 enrolled1 locationNCT06590454
Recruiting

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

Gastric CancerGastric AdenocarcinomaDysplasia+2 more
Memorial Sloan Kettering Cancer Center3,200 enrolled7 locationsNCT06370143
Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Primary myelofibrosis (PMF)Myeloproliferative DisordersMyelofibrosis+49 more
MPN Research Foundation5,000 enrolled2 locationsNCT07362225
Recruiting

The GAstric Precancerous Conditions Study

Gastric CancerHelicobacter Pylori InfectionAtrophic Gastritis+1 more
Stanford University600 enrolled1 locationNCT04191551
Recruiting
Phase 4

Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia

Gastric Intestinal Metaplasia
Yongquan Shi196 enrolled6 locationsNCT06610760
Recruiting

Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score

Artificial IntelligenceIntestinal Metaplasia of Gastric MucosaEndoscopy
Qilu Hospital of Shandong University3,000 enrolled3 locationsNCT07257796
Recruiting
Phase 4

Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

Gastric Intestinal Metaplasia
Yongquan Shi400 enrolled1 locationNCT06610266
Recruiting

Intestinal Metaplasia Cohort for Gastric Cancer Prediction

Intestinal Metaplasia of Gastric Mucosa
Seoul National University Hospital1,000 enrolled1 locationNCT06075199
Recruiting
Not Applicable

HYPNONAG : Therapeutic Communication Versus Traditional Method for Naso-gastric Intubation in Haematology

Chemotherapy EffectAplasia
Rennes University Hospital180 enrolled2 locationsNCT05790733
Recruiting

Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study

Atrophic GastritisHelicobacter PyloriIntestinal Metaplasia
Chinese University of Hong Kong260 enrolled2 locationsNCT05053945
Recruiting

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

Gastric CancerAtrophic GastritisIntestinal Metaplasia
Chinese University of Hong Kong1,300 enrolled1 locationNCT04840056
Recruiting

Cytosponge for Gastric Intestinal Metaplasia

Gastric CancerGastric Intestinal MetaplasiaGastric Atrophy
University of Cambridge226 enrolled1 locationNCT05657080
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852
Recruiting
Not Applicable

The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

Intestinal MetaplasiaBarrett's Esophagus
E-DA Hospital165 enrolled1 locationNCT05818072
Recruiting
Not Applicable

SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up

Gastric CancerAtrophic GastritisGastric Dysplasia+1 more
Instituto Portugues de Oncologia, Francisco Gentil, Porto912 enrolled1 locationNCT04613570